Cargando…
Dedifferentiated chondrosarcoma of the pelvis: clinical outcomes and current treatment
BACKGROUND: Dedifferentiated chondrosarcomas (CS) are a high-grade variant of CS that confers a 5-year survival of around 10–24%. Dedifferentiated CS arising from the pelvis confers an even worse prognosis. QUESTIONS: (1) What is the prognosis of patients with dedifferentiated CS of the pelvis? (2)...
Autores principales: | Lex, Johnathan R., Evans, Scott, Stevenson, Jonathan D., Parry, Michael, Jeys, Lee M., Grimer, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293503/ https://www.ncbi.nlm.nih.gov/pubmed/30559960 http://dx.doi.org/10.1186/s13569-018-0110-1 |
Ejemplares similares
-
Synovial Chondrosarcoma Arising in Synovial Chondromatosis
por: Evans, Scott, et al.
Publicado: (2014) -
Intraosseous conventional central chondrosarcoma does not metastasise irrespective of grade in pelvis, scapula and in long bone locations
por: Laitinen, Minna K., et al.
Publicado: (2023) -
Chondrosarcoma of the Proximal Humerus: Does the Margin Affect Survival?
por: Kask, Gilber, et al.
Publicado: (2023) -
Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials
por: Zając, Weronika, et al.
Publicado: (2023) -
Chondrosarcoma of the Pelvis: Oncologic and Functional Outcome
por: Wirbel, Reiner J., et al.
Publicado: (2000)